Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

We’re working to bring the hope of advanced medicine to more patients.

Targeting inflammation to fight cancer is a new approach with a long history.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Novartis researchers aim to preserve kidney function – and quality of life – for patients.

Novartis researchers are using data to accelerate drug development.

These stories offer a glimpse into the lives of people touched by a new era of medicine.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Alice Shaw, Global Head of Translational Clinical Oncology at Novartis, applies lessons from running clinical trials to the work of designing them.